ArticleCureus2025

Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial.

Naoki Iwanaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.